1. AB0168 NINTEDANIB (TYROSINE-KINASE INHIBITOR) INHIBITS THE TRANSITION OF CIRCULATING FIBROCYTES ISOLATED FROM SYSTEMIC SCLEROSIS PATIENTS INTO MYOFIBROBLASTS: AN IN VITROSTUDY. (2nd June 2020) Authors: Soldano, S.; Martinelli, G.; Tardito, S.; Paolino, S.; Patanè, M.; Gotelli, E.; Corallo, C.; Pizzorni, C.; Sulli, A.; Schenone, C.; Smith, V.; Cutolo, M. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1384 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAT0300 SERUM FROM "EARLY" SYSTEMIC SCLEROSIS PATIENTS ALREADY INDUCES THE ALTERNATIVELY ACTIVATED MACROPHAGE PHENOTYPE (M2) IN CULTURED HUMAN MONOCYTES. (2nd June 2020) Authors: Soldano, S.; Tardito, S.; Paolino, S.; Patanè, M.; Gotelli, E.; Corallo, C.; Pizzorni, C.; Pacini, G.; Goegan, F.; Sulli, A.; Schenone, C.; Smith, V.; Cutolo, M. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1095 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗